-
3 weeks ago | 
komen.org | Shannon Woodworth
April is Teenage and Young Adult Cancer Awareness Month and Rachel’s story exemplifies a perspective that will help many going through a similar experience. Though a breast cancer diagnosis forced her onto a path she never expected, she has emerged with wisdom, resilience and a deeper appreciation for the present.
-
3 weeks ago | 
komen.org | Shannon Woodworth
For Laurel, breast cancer was always a possibility. With a strong family history and a confirmed CHEK2 inherited gene mutation, each annual mammogram carried a question: Is this the year? In July of 2024, the answer finally came. “I went in for my regular mammogram on July 5,” Laurel recalled. “The next week, they called and said they saw something. I scheduled the diagnostic mammogram immediately.
-
1 month ago | 
komen.org | Shannon Woodworth
Susan G. Komen’s Center for Public Policy has been a proven leader in the breast cancer policy space since its inception. By empowering people and policymakers with knowledge, connecting advocates together and mobilizing communities, we’ve led efforts to spark lasting change.
-
1 month ago | 
komen.org | Shannon Woodworth
Every March, International Women’s Day is an opportunity to recognize the resilience, dedication and impact of women around the world. At Susan G. Komen, we are inspired by women every day — women who drive progress in the breast cancer space as survivors, caregivers, doctors, researchers and advocates.
-
1 month ago | 
komen.org | Shannon Woodworth
When Nisha received her breast cancer diagnosis, her world shifted instantly. As a mother of three, including a daughter born with a congenital heart disease, she had always advocated for her children’s health. Now, she found herself in the position of advocating for her own. As a Susan G. Komen employee and ShareForCures® participant, Nisha’s story underscores how sharing experiences and advocating for oneself can impact the future and improve outcomes for so many others.
-
1 month ago | 
komen.org | Shannon Woodworth
How Your Support Changes Lives When you donate to Susan G. Komen, you might wonder where your dollars go. With every donation, they embark on a powerful journey, one that brings hope where there is uncertainty, comfort where there is fear and progress where there is urgent need. That single dollar could become the research breakthrough that leads to a lifesaving treatment.
-
2 months ago | 
komen.org | Shannon Woodworth
For new Komen-funded researcher and recipient of the ASPIRE grant, Lianel Rosario, it was a personal experience at home that inspired her to focus her career on end-of-life and palliative care for Hispanic/Latina breast cancer patients and their caregivers. “My mom was diagnosed with breast cancer,” Rosario said.
-
2 months ago | 
komen.org | Shannon Woodworth
What Is Personalized Care in Breast Cancer? Breast cancer is a personal experience, with no two cases being exactly alike. For this reason, personalized care (or personalized medicine) is increasingly common in the medical landscape. For breast cancer, personalized care refers to tailored screening, treatment and support. This approach integrates genetic, biological and personal factors to improve outcomes and provide the most effective care possible. What Makes Care Personalized?
-
2 months ago | 
komen.org | Shannon Woodworth
The beginning of a new year brings hope for clinical trials, because it often means the start of new research, new discoveries and new advancements that may help to improve the lives of patients. Clinical trials are the vital connection between laboratory findings and patients in the clinic. Below, we’re shining a spotlight on some promising clinical trials in 2025.
-
2 months ago | 
komen.org | Shannon Woodworth
Breast cancer treatment has come a long way in becoming tailored to the unique features of a person and their cancer. Below, we will walk through four steps that you and your health care team can go through to help you find the treatment plan that works best for you. Decades ago, a mastectomy was the standard treatment for nearly all cases of early-stage breast cancer.
